Dare Bioscience, Inc. 8-K

What Happened

• Daré Bioscience, Inc. (DARE) filed a Form 8-K on March 26, 2026 (Item 2.02) to announce its results of operations and financial condition for the year ended December 31, 2025. The company issued a press release on that date summarizing its 2025 financial results; the press release is furnished as Exhibit 99.1 to the 8-K. The filing also includes the cover page interactive XBRL data file.

Key Details

• Filing date: March 26, 2026 (Form 8-K, Item 2.02: Results of Operations and Financial Condition).
• Reporting period: Year ended December 31, 2025.
• Press release: Issued March 26, 2026 and furnished as Exhibit 99.1 to the 8-K.
• Interactive data: Inline XBRL cover page (Exhibit 104) included for financial data extraction.

Why It Matters

• This 8-K announces Daré’s annual earnings information; investors should read the March 26 press release and any accompanying financial tables to see reported revenue, net income (or loss), cash position, and expense items that affect valuation and runway. The furnished Exhibit 99.1 and the Inline XBRL file allow quick review of the company’s reported 2025 results and make it easier to extract the data for further analysis.